Recalling India's Vaccine Triumph As Science Behind mRNA Covid Vaccines Earns 2023 Medicine Nobel
Centre Unveils World’s First Made-In-India Covid Nasal Vaccine 'iNCOVACC' By Bharat Biotech
Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt Supplies
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 Vaccine
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The Problem
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
What Can Possibly Explain WHO's Delay In Approving Covaxin?
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 Years
WHO's Emergency Use Nod For Bharat Biotech's Covaxin Delayed Till 5 October: Report
Bharat Biotech's Covaxin May Get WHO's Approval By End Of September, Says Dr V K Paul
Bharat Biotech's Covid-19 Nasal Vaccine Shows Promising Results: Centre
Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022
How August Turned Out To Be A Major Inflection Point For India’s Vaccination Effort
Why Adar Poonawalla Should Get Padma Vibhushan This Year
Gujarat: Bharat Biotech Begins Commercial Roll Out Of Covaxin From New Facility In Ankleshwar
Single-Dose Of Covaxin On Covid-Recovered People Gives Similar Response As Two Doses On Uninfected: ICMR Study
ZyCoV-D Vaccine Likely To Be Available For Adolescents In Four Weeks: Report
Johnson & Johnson Seeks Approval To Conduct Covid-19 Vaccine Trial On Children In India
Bharat Biotech's Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster Dose
What We Know About Union Health Minister's Meeting With WHO Chief Scientist
Bharat Biotech's Nasal Vaccine For Covid-19 Set To Advance Into Phase 2 Clinical Trial
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
Boosting Vaccine Availability: Govt Gives Approval To Bharat Biotech's Gujarat Plant To Produce Covaxin
'Every Covaxin Batch Subjected To Over 200 Quality Tests': Bharat Biotech Rubbishes 'False Narratives' Against Its Vaccine
Covaxin Receives 'Good Manufacturing Practice' Compliance Certificate From Hungary
